Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
28 Pages - GMD12102
$1,500.00

Summary

Global Markets Direct’s, ‘Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2014’, provides an overview of the Laboratorios Farmaceuticos Rovi, S.A.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Farmaceuticos Rovi, S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Laboratorios Farmaceuticos Rovi, S.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Laboratorios Farmaceuticos Rovi, S.A.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Laboratorios Farmaceuticos Rovi, S.A.’s pipeline products

Reasons to buy

- Evaluate Laboratorios Farmaceuticos Rovi, S.A.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Laboratorios Farmaceuticos Rovi, S.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Laboratorios Farmaceuticos Rovi, S.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Laboratorios Farmaceuticos Rovi, S.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Farmaceuticos Rovi, S.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Laboratorios Farmaceuticos Rovi, S.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Laboratorios Farmaceuticos Rovi, S.A. Snapshot 5
Laboratorios Farmaceuticos Rovi, S.A. Overview 5
Key Information 5
Key Facts 5
Laboratorios Farmaceuticos Rovi, S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products Glance 10
Laboratorios Farmaceuticos Rovi, S.A. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Laboratorios Farmaceuticos Rovi, S.A. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Laboratorios Farmaceuticos Rovi, S.A. - Drug Profiles 12
ardeparin sodium 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
risperidone 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
letrozole 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
olanzapine 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
paliperidone 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
RO-17 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Analysis 19
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Target 19
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Route of Administration 20
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Molecule Type 21
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Mechanism of Action 22
Laboratorios Farmaceuticos Rovi, S.A. - Recent Pipeline Updates 23
Laboratorios Farmaceuticos Rovi, S.A. - Dormant Projects 24
Laboratorios Farmaceuticos Rovi, S.A. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables
Laboratorios Farmaceuticos Rovi, S.A., Key Information 5
Laboratorios Farmaceuticos Rovi, S.A., Key Facts 5
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Indication, 2014 7
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Stage of Development, 2014 8
Laboratorios Farmaceuticos Rovi, S.A. - Monotherapy Products in Pipeline, 2014 9
Laboratorios Farmaceuticos Rovi, S.A. - Phase II, 2014 10
Laboratorios Farmaceuticos Rovi, S.A. - Preclinical, 2014 11
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Target, 2014 19
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Route of Administration, 2014 20
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Molecule Type, 2014 21
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Mechanism of Action, 2014 22
Laboratorios Farmaceuticos Rovi, S.A. - Recent Pipeline Updates, 2014 23
Laboratorios Farmaceuticos Rovi, S.A. - Dormant Developmental Projects,2014 24
Laboratorios Farmaceuticos Rovi, S.A., Other Locations 25
Laboratorios Farmaceuticos Rovi, S.A., Subsidiaries 26

List of Figures
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Indication, 2014 7
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Stage of Development, 2014 8
Laboratorios Farmaceuticos Rovi, S.A. - Monotherapy Products in Pipeline, 2014 9
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Target, 2014 19
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Route of Administration, 2014 20
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Molecule Type, 2014 21
Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Top 10 Mechanism of Action, 2014 22

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax